Ocular myasthenia gravis associated with euthyroid ophthalmopathy

Muscle and Nerve

Volumn 28, Issue 6, 2003, Pages 764-766

  Kusuhara, Tomohiko ^a   Nakajima, Masashi ^a,b   Imamura, Akiko ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO ROSAI HOSPITAL   (Japan)

Author keywords

Autoantibodies; Euthyroid ophthalmopathy; Graves' disease; Magnetic resonance imaging; Myasthenia gravis; Ophthalmoplegia

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; EDROPHONIUM CHLORIDE; IMMUNOGLOBULIN; LIOTHYRONINE; METHYLPREDNISOLONE; THYROTROPIN; THYROXINE;

AGED; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIPLOPIA; EUTHYROIDISM; EYE DISEASE; EYE MOVEMENT DISORDER; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IRRADIATION; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR MYASTHENIA GRAVIS; PRIORITY JOURNAL; PTOSIS; SYSTEMIC THERAPY;

AGED; ANTI-INFLAMMATORY AGENTS; EYE DISEASES; FEMALE; GRAVES DISEASE; HUMANS; IMMUNIZATION, PASSIVE; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE; MYASTHENIA GRAVIS; VISION DISORDERS;

EID: 0344012215     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10471     Document Type: Article

References (13)

1. Adams RD, Victor M. Principles of neurology. New York: McGraw-Hill; 1993. 1254 p.
2. Bartalena L, Marcocci C, Laddaga CM, Lepri G, Andreani D, Gavallacci G, Baschieri L, Pinchera A. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983;56:1139-1144.
3. Beck K. Thyroid antibodies in endocrine ophthalmopathy: a review. Acta Endocrinol 1989;121(Suppl 2):117-122.
4. Char DH. Thyroid eye disease. Br J Ophthalmol 1996;80:922-926.
5. Gunji K, Kubota S, Swanson J, Kiljanski J, Bednarczuk T, Wengrowicz S, Salvi M, Wall JR. Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens. Thyroid 1998;8:553-556.
6. Kashiwai T, Tada H, Asahi K, Hidaka Y, Tamaki H, Iwatani Y, Amino N. Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease. Endocr J 1995;42:405-412.
7. Kaspar M, Archibald C, De BA, Li AW, Yamada M, Chang CH, Kahaly G, Wall JR. Eye muscle antibodies and subtype of thyroid-ssociated ophthalmopathy. Thyroid 2002;12:187-191.
8. Marinò M, Barbesino G, Pinchera A, Manetti L, Ricciardi R, Rossi B, Muratorio A, Braverman LE, Mariotti S, Chiovato L. Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis. Thyroid 2000;10:799-802.
9. Plested CP, Tang T, Spreadbury I, Littleton ET, Kishore U, Vincent A. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG. Neurology 2002;59:1682-1688.
10. Rothfus WE, Curtin HD. Extraocular muscle enlargement: a CT review. Radiology 1984;151:677-681.
11. Siatkowski RM, Capo H, Byrne SF, Gendron EK, Flynn JT, Munoz M, Feuer WJ. Clinical and echographic findings in idiopathic orbital myositis. Am J Ophthalmol 1994;118:343-350.
12. Wang ZY, Diethelm-Okita B, Okita DK, Kaminski HJ, Howard JF, Conti-Fine BM. T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis. J Neuroimmunol 2000;108:29-39.
13. Zimmermann CW, Eblen F. Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ. Clin Invest 1993;71:445-451.